Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for sedation during elective atrial fibrillation cardioversion
IRCT20201028049181N3Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Dexmedetomidine with Propofol (2 arms). Primary endpoints: Cardioversion success, Patient satisfaction and 7 more. Started Jul 2026; status: recruiting.
02
Drugs
dexmedetomidinepropofol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20201028049181N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049181N3.